CAXTON ASSOCIATES LLP
Position in PACB — Pacific Biosciences Of California, Inc.
CIK 2051323
LONDON, X0
Position in PACB
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$466,131
-$733,892 QoQ
Shares Held
353,130
-45.0% QoQ
Ownership
0.114%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PACB Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026CAXTON ASSOCIATES LLP holds $63,016,202 across 7 Medical Devices names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PEN |
Penumbra Inc
|
179,384 | $56,640,498 | |
| 2 | BIO |
Bio-Rad Laboratories, Inc.
|
13,875 | $4,073,838 | |
| 3 | NEOG |
Neogen Corp
|
149,164 | $1,340,984 | |
| 4 | 16,855 | $419,352 | |||
| 5 | HAE |
Haemonetics Corp
|
3,426 | $256,950 | |
| 6 | TXG |
10x Genomics, Inc.
|
6,044 | $231,726 | |
| 7 | CTKB |
Cytek Biosciences, Inc.
|
11,931 | $52,854 |
All Filings in PACB
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $466,131 | 353,130 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $1,200,023 | 641,724 | Shares | Sole | 2026-02-13 | |
| No filing history on record for this holder in this stock. | ||||||